| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Pulmonary disease, chronic obstructive, severe early-onset | 0.456 | 0.885 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 2017 | 2019 | |||||||||
|
ribonuclease A family member 2 | 0.621 | 0.692 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2019 | 2019 | |||||||||
|
lipocalin 1-like | 0.663 | 0.577 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 | |||||||||
|
toll like receptor adaptor molecule 1 | 0.593 | 0.846 |
|
phenotype | 0.010 | None | 1.000 | 1 | 1 | 2014 | 2014 | |||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
Pulmonary function | 0.544 | 0.731 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
ribonuclease A family member 3 | 0.490 | 0.808 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | |||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
serine peptidase inhibitor Kazal type 5 | 0.604 | 0.654 | 4.8E-28 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
dynein axonemal heavy chain 1 | 0.656 | 0.615 | 1.5E-26 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
cadherin related family member 3 | 0.805 | 0.192 | 2.3E-24 |
|
phenotype | 0.030 | None | 1.000 | 3 | 2 | 2015 | 2018 | ||||||||
|
insulin receptor related receptor | 0.508 | 0.808 | 5.4E-24 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
toll like receptor 1 | 0.496 | 0.808 | 5.9E-23 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
interleukin 9 receptor | 0.659 | 0.654 | 2.7E-22 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
peptidase M20 domain containing 1 | 0.821 | 0.308 | 1.9E-18 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
WD repeat and HMG-box DNA binding protein 1 | 0.529 | 0.846 | 4.4E-18 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | ||||||||
|
cytochrome P450 family 1 subfamily A member 1 | 0.436 | 0.846 | 1.1E-17 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
phenotype | 0.010 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
transient receptor potential cation channel subfamily V member 1 | 0.446 | 0.885 | 1.0E-16 |
|
phenotype | 0.010 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
transient receptor potential cation channel subfamily V member 4 | 0.457 | 0.808 | 2.2E-16 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 2 | 2010 | 2010 | ||||||||
|
arachidonate 12-lipoxygenase, 12S type | 0.558 | 0.692 | 1.4E-15 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
TNF receptor superfamily member 13B | 0.558 | 0.769 | 2.1E-15 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 |